Perioperative Inflammation and Breast Cancer Outcome
It is increasingly recognized the NSAIDS (nonsteroidal antiinflammatory drug) might prevent the several cancers. In breast cancer, the role of NSAIDS (nonsteroidal antiinflammatory drug) has been suggested.However, there was no consistent results. surgery is main cause of inflammation for cancer patients. Therefore, we want to know the association between prevention of perioperative inflammation with NSAIDS and breast cancer outcomes.
Breast Neoplasms
DRUG: NSAIDS (ketorolac and ibuprofen)
disease free survival, 5 years
overall survival, 5years
neutrophil-lymphocyte ratio (NLR), albumin, inflammatory blood lab (CRP), POD 1-2 weeks (immediate postoperative period)
It is increasingly recognized the NSAIDS (nonsteroidal antiinflammatory drug) might prevent the several cancers. In breast cancer, the role of NSAIDS (nonsteroidal antiinflammatory drug) has been suggested.However, there was no consistent results. surgery is main cause of inflammation for cancer patients. Therefore, we want to know the association between prevention of perioperative inflammation with NSAIDS and breast cancer outcomes.